Proathlete Wealth Management »

Amgen shares owned by Proathlete Wealth Management

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Proathlete Wealth Management from 13F filings

Historical chart of Proathlete Wealth Management investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Proathlete Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Proathlete Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.9k 15 327.27
2025-06-30 $1.1k 4 279.00

More positions owned by Proathlete Wealth Management

Ishares Core S&p 500 Etf Uit Exchange Traded (IVV)
Ishares Russell 1000 Growth Etf Uit Exchange Traded (IWF)
Ishares Russell 1000 Value Etf Uit Exchange Traded (IWD)
Ishares Core S&p Small Cap Etf Uit Exchange Traded (IJR)
Invsc Qqq Trust Srs 1 Etf Uit Exchange Traded (QQQ)
Ishares Core Msci Eafe Etf Uit Exchange Traded (IEFA)
Avantis Us Small Cap Value Etf Uit Exchange Traded (AVUV)
Ishares Bitcoin Etf Uit Exchange Traded (IBIT)
Vanguard Ftse Emerging Markets Etf Uit Exchange Traded (VWO)
Ishares Short Duratn Bndactv Etf Uit Exchange Traded (NEAR)
Ishares 3-7 Year Trery Bond Etf Uit Exchange Traded (IEI)
Ishares National Muni Bond Etf Uit Exchange Traded (MUB)
Avantis International Equity Etf Uit Exchange Traded (AVDE)
Microsoft Corp Common Stock (MSFT)
Vanguard Ftse Developed Markets Etf Uit Exchange Traded (VEA)

View all positions for Proathlete Wealth Management

Top funds holding Amgen

Vanguard Group
BlackRock
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Geode Capital Management
Charles Schwab Investment Management
PRIMECAP Management Company
Wells Fargo & Company
Norges Bank Investment Management
Northern Trust
Invesco
Royal Bank of Canada
Capital Research Global Investors
Ubs Global Asset Management Americas

View all funds holding Amgen